Two House committees have demanded the Food and Drug Administration provide documents related to the approval of Biogen Alzheimer’s drug Aduhelm. “We are concerned by apparent anomalies in FDA’s processes surrounding its review,” committee chairs wrote. (NYT)

Pharma companies are launching a lobbying campaign against a proposed Democratic overhaul of prescription drug pricing policy. The industry argues that its role in fighting the COVID-19 pandemic should be highlighted as one reason to avoid restrictions on drug pricing. (Politico)

Families who lost loved ones in the opioid epidemic expressed anger after a bankruptcy court judge approved a plan that would protect the Sackler family from future opioid lawsuits. In the settlement, Purdue Pharma will be dissolved, but the Sackler family will not be required to give up their fortune. (STAT)

The jury for Elizabeth Holmes’ criminal trial has been selected and will include seven men and five women. The former CEO and founder of health tech company Theranos was charged with fraud after making false claims about the company’s blood tests. (CNN)

The U.S. will invest $3 billion in the vaccine supply chain as part of its effort to become a lead supplier of vaccines globally, a White House COVID advisor said. The money will mainly go toward manufacturing and facilities that fill vaccine vials. (Reuters